Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug

NCT01800175 is registered in ClinicalTrials.gov with Ocular Therapeutix, Inc. as lead sponsor.

NCT NCT01800175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug
Lead sponsor
Ocular Therapeutix, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2013
Completion date
Not reported
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects